Role of nitric oxide in the inhibition of cytochrome P450 in the liver of mice infected with Chlamydia trachomatis

Biochemical Pharmacology

Volumn 55, Issue 11, 1998, Pages 1835-1842

  Khatsenko, Oleg G ^a   Barteneva, Natalie S ^a   De la Maza, Luis M ^a   Kikkawa, Yutaka ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlamydia trachomatis; Cytochrome P450; Nitric oxide

Indexed keywords

CYTOCHROME P450; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CHLAMYDIASIS; DISEASE COURSE; ENZYME INHIBITION; FEMALE; IMMUNOBLOTTING; LIVER METABOLISM; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN CONTENT; RAT;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; ENZYME INHIBITORS; FEMALE; ISOENZYMES; LIVER; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES;

EID: 0032101578     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00066-5     Document Type: Article

References (35)

1. Weinberg J.B., Chapman H.A. Jr, Hibbs J.B. Jr. Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol. 121:1978;72-80.
2. Clark I.A., Rockett K.A. Nitric oxide and parasitic disease. Adv Parasitol. 37:1996;1-56.
3. Schachter J. Pathogenesis of chlamydial infections. Pathol Immunopathol Res. 8:1989;206-220.
4. Igietseme J.U., Uriri I.M., Hawkins R., Rank R.G. Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia. J Leukoc Biol. 59:1996;656-662.
5. Mayer J., Woods M.L., Vavrin Z., Hibbs J.B. Jr. Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect Immun. 61:1993;491-497.
6. Igietseme J.U. The molecular mechanism of T-cell control of Chlamydia in mice: Role of nitric oxide. Immunology. 87:1996;1-8.
7. Gross S.S., Wolin M.S. Nitric oxide: Pathophysiological mechanisms. Annu Rev Physiol. 57:1995;737-769.
8. Porter T.D., Coon M.J. Cytochrome P450: Multiplicity of isoforms, substrates and catalytic and regulatory mechanisms. J Biol Chem. 266:1991;13469-13472.
9. Moochhala S.M. Alteration of drug biotransformation by interferon and host defense mechanism. Ann Acad Med Singapore. 20:1991;13-18.
10. Khatsenko O.G., Gross S.S., Rifkind A.R., Vane J.R. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA. 90:1993;11147-11151.
11. Stadler J., Trockfeld J., Schmalix W.A., Brill T., Siewert J.R., Greim H., Doehmer J. Inhibition of cytochromes P4501A by nitric oxide. Proc Natl Acad Sci USA. 91:1994;3559-3563.
12. Muller C.M., Scierka M.S., Stiller R.L., Kim Y-M, Cook D.R., Lancaster J.R., Buffington C.W., Watkins W.D. Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin. Anesthesiology. 84:1996;1435-1442.
13. Barteneva N., Theodor I., Peterson E.M., de la Maza L.M. Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect Immun. 64:1996;4830-4833.
14. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 272:1970;680-685.
15. Khatsenko O.G., Kikkawa Y. Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver. J Pharmacol Exp Ther. 280:1997;1463-1470.
16. Burke M.D., Mayer R.T. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chem Biol Interact. 45:1983;243-258.
17. Giachelli C.M., Omiecinski C.J. Developmental regulation of cytochrome P450 genes in the rat. Mol Pharmacol. 31:1987;477-484.
18. Omiecinski C.J., Redlich C.A., Costa P. Induction and developmental expression of cytochrome P4501A1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res. 50:1990;4315-4321.
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
20. 16α) of testosterone 16α-hydroxylase in mouse liver, chromosome localization, and cloning of P450 cDNA. Biochemistry. 27:1988;6434-6443.
21. Renton K.W. Factors affecting drug biotransformation. Clin Biochem. 19:1986;72-75.
22. Bavoil P.M., Hsia R.C., Rank R.G. Prospects for a vaccine against Chlamydia genital disease: Microbiology and pathogenesis. Bull Inst Pasteur. 94:1996;5-54.
23. Stark M.E., Szurszewski J.H. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology. 103:1992;1928-1949.
24. Peterson T.C., Renton K.W. Depression of cytochrome P450-dependent drug biotransformation in hepatocytes after the activation of the reticuloendothelial system by dextran sulfate. J Pharmacol Exp Ther. 229:1984;299-304.
25. Armstrong S.G., Renton K.W. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice. Mol Pharmacol. 43:1993;542-547.
26. Oyekan A.O. The suppression by lipopolysaccharide of cytochrome P450-dependent renal vasodilation in the rat is mediated by nitric oxide. Eur J Pharmacol. 277:1995;123-132.
27. Kim Y-M, Bergonia H.A., Muller C., Pitt B.R., Watkins W.D., Lancaster J.R. Nitric oxide and intracellular heme. Adv Pharmacol. 34:1995;277-291.
28. Chamulitrat W., Jordan S.J., Mason R.P., Litton A.L., Wilson J.G., Wood E.R., Wolberg G., Molina y Vedia L. Targets of nitric oxide in a mouse model of liver inflammation by Corynebacterium parvum. Arch Biochem Biophys. 316:1995;30-37.
29. G-monomethyl-L-arginine on the hepatic suppression. Xenobiotica. 26:1995;381-394.
30. Donato M.T., Guillen M.I., Jover R., Castell J.V., Gomez-Lechon M.J. Nitric oxide-mediated inhibition of cytochrome P450 by interferon-γ in human hepatocytes. J Pharmacol Exp Ther. 281:1997;484-490.
31. Hodgson P.D., Renton K.W. The role of nitric oxide generation in interferon-evoked cytochrome P450 down-regulation. Int J Immunopharmacol. 12:1995;995-1000.
32. Carlson T.J., Billings R.E. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P450. Mol Pharmacol. 49:1996;796-801.
33. Melillo G., Cox G.W., Biragyn A., Sheffler L.A., Varesio L. Regulation of nitric-oxide synthase mRNA expression by interferon-γ and picolinic acid. J Biol Chem. 269:1994;8128-8133.
34. Linnemann C.C. Jr, Heaton C.L., Ritchey M. Treatment of Chlamydia trachomatis infections Comparison of 1- and 2-g doses of erythromycin daily for seven days. Sex Transm Dis. 14:1987;102-106.
35. Alvares A.P., Ueng T-H, Scheibel L.W., Hollingdale M.R. Impairment of hepatic cytochrome P-450-dependent monooxygenases by the malaria parasite Plasmodium berghei. Mol Biochem Parasitol. 13:1984;277-282.